Correlation Between Quorum Information and Cipher Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Quorum Information and Cipher Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Quorum Information and Cipher Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Quorum Information Technologies and Cipher Pharmaceuticals, you can compare the effects of market volatilities on Quorum Information and Cipher Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Quorum Information with a short position of Cipher Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Quorum Information and Cipher Pharmaceuticals.

Diversification Opportunities for Quorum Information and Cipher Pharmaceuticals

-0.13

Correlation Coefficient

Quorum Information  Cipher Pharmaceuticals

Good diversification

The 3 months correlation between Quorum and Cipher is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Quorum Information Technologie and Cipher Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cipher Pharmaceuticals and Quorum Information is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Quorum Information Technologies are associated (or correlated) with Cipher Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cipher Pharmaceuticals has no effect on the direction of Quorum Information i.e., Quorum Information and Cipher Pharmaceuticals go up and down completely randomly.

Pair Corralation between Quorum Information and Cipher Pharmaceuticals

Assuming the 90 days horizon Quorum Information Technologies is expected to under-perform the Cipher Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Quorum Information Technologies is 1.21 times less risky than Cipher Pharmaceuticals. The stock trades about -0.18 of its potential returns per unit of risk. The Cipher Pharmaceuticals is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  1,111  in Cipher Pharmaceuticals on April 20, 2025 and sell it today you would earn a total of  122.00  from holding Cipher Pharmaceuticals or generate 10.98% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Quorum Information Technologie  vs.  Cipher Pharmaceuticals

Quorum Information

Risk-Adjusted Performance

Very Weak

Over the last 90 days Quorum Information Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in August 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Cipher Pharmaceuticals

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Cipher Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal technical indicators, Cipher Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Pair Trading with Quorum Information and Cipher Pharmaceuticals

The main advantage of trading using opposite Quorum Information and Cipher Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Quorum Information position performs unexpectedly, Cipher Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cipher Pharmaceuticals will offset losses from the drop in Cipher Pharmaceuticals' long position.

The idea behind Quorum Information Technologies and Cipher Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.